Fumiaki Isohashi

Monotherapeutic High-Dose-Rate Brachytherapy for Prostate Cancer: Five-Year Results of an Extreme Hypofractionation Regimen With 54 Gy in Nine Fractions

Yasuo Yoshioka, Koji Konishi, Iori Sumida et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 108 citations

Urology, Radiation Therapy, Brachytherapy +4

Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer

Seiji Mabuchi, Yuri Matsumoto, Fumiaki Isohashi et al. · Gynecologic Oncology · 2011 · 97 citations

Pretreatment Leukocytosis, Cervical Cancer Management, Cervical Cancer +11

High-Dose-Rate Brachytherapy as Monotherapy for Intermediate- and High-Risk Prostate Cancer: Clinical Results for a Median 8-Year Follow-Up

Yasuo Yoshioka, Fumiaki Isohashi, Yuji Seo et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 89 citations

Urology, High-risk Prostate Cancer, Radiation Therapy +7

Radiotherapy targeting cancer stem cells: current views and future perspectives.

Kazuhiko Ogawa, Yasuo Yoshioka, Fumiaki Isohashi et al. · PubMed · 2013 · 77 citations

Potential Therapies, Stem Cell Biology, Tumor Biology +17

Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma

Yutaka Takahashi, Tomohiro Yasui, Kazumasa Minami et al. · Oncotarget · 2019 · 75 citations · Full text